Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
3,172,831
-
Number of holders
-
16
-
Total 13F shares, excl. options
-
701,621
-
Shares change
-
-20,615
-
Total reported value, excl. options
-
$149,288
-
Value change
-
-$56,574
-
Put/Call ratio
-
0%
-
Number of buys
-
7
-
Number of sells
-
-4
-
Price
-
$0.2135
Significant Holders of 180 Life Sciences Corp. - Common Stock, $0.0001 par value (ATNF) as of Q4 2023
20 filings reported holding ATNF - 180 Life Sciences Corp. - Common Stock, $0.0001 par value as of Q4 2023.
180 Life Sciences Corp. - Common Stock, $0.0001 par value (ATNF) has 16 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 701,621 shares
of 3,172,831 outstanding shares and own 22% of the company stock.
Largest 10 shareholders include CHARLES SCHWAB INVESTMENT MANAGEMENT INC (348,908 shares), Virtu Financial LLC (76,141 shares), CITADEL ADVISORS LLC (64,970 shares), VANGUARD GROUP INC (47,852 shares), RENAISSANCE TECHNOLOGIES LLC (43,336 shares), HRT FINANCIAL LP (37,490 shares), GEODE CAPITAL MANAGEMENT, LLC (30,548 shares), MILLENNIUM MANAGEMENT LLC (17,440 shares), BlackRock Inc. (14,654 shares), and Tower Research Capital LLC (TRC) (9,784 shares).
This table shows the top 16 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.